DermTech Inc. (DMTK) PT Lowered to $1.50 at Stephens 'due to concerns around long-term viability'
Tweet Send to a Friend
Stephens analyst Mason Carrico lowered the price target on DermTech Inc. (NASDAQ: DMTK) to $1.50 (from $2.50) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
